Abstract
HyperlynX: A Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and Radiotherapy in Patients with Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have